Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women

Paul Roschger(Unfallkrankenhaus Meidling), S Rinnerthaler(Hanusch Hospital), John Yates(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gideon A. Rodan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter Fratzl(Erich Schmid Institute of Materials Science), K. Klaushofer(Hanusch Hospital)
Bone
August 1, 2001
10.1016/s8756-3282(01)00485-9
Cited by 385

Abstract

Related Papers

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study
H. A. P. Pols, Dieter Felsenberg, David A. Hanley et al.|Osteoporosis International|1999|594
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women
Georges Boivin, Pascale Chavassieux, Arthur C. Santora et al.|Bone|2000|576
Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
Pascale Chavassieux, M. Arlot, C.V. Reda et al.|Journal of Clinical Investigation|1997|524
Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies
Paul Roschger, Peter Fratzl, J. Eschberger et al.|Bone|1998|455
Static and dynamic bone histomorphometry in children with osteogenesis imperfecta
Frank Rauch, Rose Travers, A. M. Parfitt et al.|Bone|2000|327